NCT00988117 The Effects of the Rivastigmine Patch on Parkinson's Disease With Memory and/or Thinking Problems Status COMPLETED Phase PHASE4
NCT00986882 To Evaluate the Safety, Tolerability and Analgesic Efficacy of SAF312 in Postoperative Dental Pain Patients Status COMPLETED Phase PHASE2
NCT00986414 Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease Status COMPLETED Phase PHASE2
NCT00984113 Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment Status TERMINATED Phase PHASE1
NCT00982124 An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta Status COMPLETED Phase PHASE3
NCT00981799 Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL Status TERMINATED Phase PHASE1/PHASE2
NCT00978965 Identification of Patients With High Probability of Poorly Responding to Therapy With Mycophenolic Acid Prodrugs Status COMPLETED Phase N/A
NCT00978432 Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Status TERMINATED Phase PHASE2
NCT00976248 Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia Status COMPLETED Phase PHASE2
NCT00976222 Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments Status COMPLETED Phase PHASE4
NCT00973349 Safety and Immunogenicity of A/H1N1-SOIV (Swine Flu) Vaccine With and Without Adjuvant in Non-Elderly and Elderly Adults Status COMPLETED Phase PHASE2/PHASE3
NCT00972335 Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma Status TERMINATED Phase PHASE2
NCT00968253 RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT00967044 Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00956761 Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010 Status COMPLETED Phase PHASE2
NCT00956449 Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects Status COMPLETED Phase PHASE2
NCT00956410 To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients Status COMPLETED Phase PHASE2